Skip to content
2000
Volume 9, Issue 2
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

The filoviruses, Ebola (EBOV) and Marburg (MARV), are among the deadliest of human pathogens, causing acute diseases typified by rapidly fatal hemorrhagic fevers. Upon filoviral infection, innate immune cells become paralyzed and lose the capacity to properly co-stimulate and activate filovirus-specific, T-cell responses. Deleterious inflammation and upregulation of co-inhibitory molecules expressed by monocytic lineage cells (e.g., dendritic cells) and their co-inhibitory receptors on T- and B-cells may lead to incomplete humoral and T-cell immunity, anergy, exhaustion, apoptosis, and subsequent immune subversion. Hence, the dysregulation of inflammatory and co-inhibitory molecules may be exploited by filoviruses to further deteriorate host immune responses, ultimately leading to fulminant infections in susceptible species. Thus, in light of accumulating scientific observations, the challenge is now to characterize the molecular mechanisms that may result in rational strategies leading to new therapeutics and vaccines.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/156652409787581628
2009-03-01
2025-09-18
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/156652409787581628
Loading

  • Article Type:
    Research Article
Keyword(s): anergy; co-inhibition; dendritic cells; Filovirus; inflammation; programmed death
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test